GenicBio Intelligence Profile
Research Incomplete
Research coverage for this vendor is 91%. Our research on GenicBio remains incomplete — what we have verified so far is published below, and research is continuing.
Still to research:
- Public summary reviewed
Overview#
GenicBio is a Shanghai, China-based custom peptide synthesis and amino-acid supplier (brand operating since the domain's 2009 registration; current licensed entity 上海捷妮泰生物科技有限公司, USCC 91310117MA1J38AAXB, formed 2018-11-08, legal representative 刘志琼/Liu Zhiqiong) selling directly to research institutions worldwide, including U.S. buyers, through its own email/fax ordering channel — USD/EUR invoicing, wire transfer or PayPal, FedEx/DHL delivery from China in 3-4 days at a flat USD 40 fee. GATE: passes on direct U.S. sales channel only; no U.S. legal entity, office, address, or phone exists. Testing evidence is entirely in-house and private: HPLC/MS reports are supplied with each order, but no COAs are published, no independent laboratory is named, and no verification portal exists, so testing claims are unverifiable from public sources. All defined regulatory searches (FDA warning letters, recalls, import alerts, FTC, state AG, civil litigation, criminal/injunctive) returned No Record Found in the defined search. Material caveats are identity-related: the About page's 'GenicBio Limited' does not match the registered Chinese entity, the footer-linked license registers a different domain (genicbio-tech.com), the domain predates the entity by ~9.5 years, and three different Shanghai addresses appear across sources. Contracts are governed by Chinese law and Chinese courts, which limits U.S. buyer recourse. No serious (High/Critical) findings.
Company Identity#
Domain and Digital Identity#
Regulatory and Legal History#
Testing and COA Evidence#
Payment, Refund and Shipping#
Material Changes#
No material changes recorded.